Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents.

Spivak B, Gonen N, Mester R, Averbuch E, Adlersberg S, Weizman A.

Int Clin Psychopharmacol. 1996 Sep;11(3):207-9.

PMID:
8923101
2.

Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.

Spivak B, Weizman A, Wolovick L, Hermesh H, Tyano S, Munitz H.

Acta Psychiatr Scand. 1990 Feb;81(2):168-9.

PMID:
1970216
3.

Neuroleptic malignant syndrome after neuroleptic discontinuation.

Amore M, Zazzeri N.

Prog Neuropsychopharmacol Biol Psychiatry. 1995 Dec;19(8):1323-34.

PMID:
8868212
4.

[Neuroleptic malignant syndrome. Case reports].

Berardi D, Troia M, Veronesi L, Ferrari G.

Minerva Psichiatr. 1994 Dec;35(4):199-219. Review. Italian.

PMID:
7861943
5.

Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.

Aruna AS, Murungi JH.

Ann Pharmacother. 2005 Jun;39(6):1131-5. Epub 2005 Apr 19.

PMID:
15840734
6.

Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.

Liu PY, Wu PC, Chen CY, Chen YC.

Gen Hosp Psychiatry. 2011 Jan-Feb;33(1):84.e5-7. doi: 10.1016/j.genhosppsych.2010.10.009. Epub 2010 Dec 23.

PMID:
21353143
7.

Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.

Lee JW, Robertson S.

Ann Clin Psychiatry. 1997 Sep;9(3):165-9.

PMID:
9339882
8.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
9.

Neuroleptic malignant syndrome associated with clozapine treatment.

Tsai G, Crisostomo G, Rosenblatt ML, Stern TA.

Ann Clin Psychiatry. 1995 Jun;7(2):91-5.

PMID:
8556099
10.

Neuroleptic malignant syndrome presenting without initial fever: a case report.

Totten VY, Hirschenstein E, Hew P.

J Emerg Med. 1994 Jan-Feb;12(1):43-7. Review.

PMID:
8163804
11.

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.

Viguera AC, Baldessarini RJ, Hegarty JD, van Kammen DP, Tohen M.

Arch Gen Psychiatry. 1997 Jan;54(1):49-55.

PMID:
9006400
12.

Neuroleptic malignant syndrome following abrupt anti-cholinergic withdrawal: a case report.

Guru S, Vanamoorthy U, Loganathan S, Varghese M.

Asian J Psychiatr. 2014 Dec;12:158-9. doi: 10.1016/j.ajp.2014.05.007. Epub 2014 Jun 2. No abstract available.

PMID:
25440569
13.

Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.

Bottlender R, Jäger M, Hofschuster E, Dobmeier P, Möller HJ.

Pharmacopsychiatry. 2002 May;35(3):119-21.

PMID:
12107858
14.

[A study of neuroleptic malignant syndrome in the presenium and senium].

Suzuki I, Honma H, Watanabe N, Matsubara S, Koyama T.

Seishin Shinkeigaku Zasshi. 1998;100(6):387-97. Japanese.

PMID:
9745353
15.

Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.

Ozen ME, Yumru M, Savas HA, Cansel N, Herken H.

World J Biol Psychiatry. 2007;8(1):42-4.

PMID:
17366349
16.

Neuroleptic malignant syndrome and clozapine withdrawal at the same time?

Margetić B, Aukst-Margetić B.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):145-7.

PMID:
15610957
17.

Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.

Tanii H, Fujita K, Okazaki Y.

Am J Psychiatry. 2006 Mar;163(3):547-8. No abstract available.

PMID:
16513884
18.

[Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].

Ben Hadj Ali B, Dogui M, Ben Ammou S, Lôo H.

Encephale. 1995 May-Jun;21(3):209-15. French.

PMID:
7649071
19.

Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.

Gönner F, Baumgartner R, Schüpbach D, Merlo MC.

Psychopharmacology (Berl). 1999 Jun;144(4):416-8.

PMID:
10435416
20.

Pathogenesis and treatment of neuroleptic malignant syndrome.

Ebadi M, Pfeiffer RF, Murrin LC.

Gen Pharmacol. 1990;21(4):367-86. Review.

PMID:
1974219

Supplemental Content

Support Center